David Lebovitz
Stock Analyst at Citigroup
(2.47)
# 770
Out of 5,368 analysts
127
Total ratings
76.36%
Success rate
16.73%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BMRN Biomarin Pharmaceuti... | Maintains: Neutral | 82 78 | 56.2 | 38.79% | 4 | May 2, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Strong Buy | 338 351 | 307.82 | 14.03% | 31 | Mar 21, 2025 | |
MDGL Madrigal Pharmaceuti... | Maintains: Strong Buy | 378 469 | 295.82 | 58.54% | 4 | Feb 27, 2025 | |
CRNX Crinetics Pharmaceut... | Maintains: Strong Buy | 70 74 | 31.77 | 132.92% | 2 | Nov 14, 2024 | |
MIRM Mirum Pharmaceutical... | Maintains: Strong Buy | 37 38 | 49.6 | -23.39% | 1 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 29 17 | 51.19 | -66.79% | 5 | Oct 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 111 92 | 127.97 | -28.11% | 6 | Feb 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 57 54 | 62.91 | -14.16% | 5 | Aug 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 408 372 | n/a | n/a | 5 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | n/a | n/a | 5 | May 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 38 35 | 35.58 | -1.63% | 6 | May 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 16 17 | 1.52 | 1018.42% | 11 | Apr 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 11 | 0.62 | 1674.19% | 7 | Feb 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 193 220 | n/a | n/a | 5 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 500 | n/a | n/a | 2 | Dec 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 45 44 | n/a | n/a | 10 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 194 199 | 170.62 | 16.63% | 11 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 510 480 | 4.4 | 10809.09% | 2 | Nov 3, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 27 26 | n/a | n/a | 2 | Aug 13, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 119 129 | n/a | n/a | 3 | Mar 6, 2018 |